Dr. Michael Keidar has received $5.3 million in funding from U.S. Patent Innovations LLC for a five-year project titled “Plasma Medicine Initiative” (PMI). PMI aims to revolutionize cancer therapy by introducing a novel modality in cancer treatment that uses a cool-to-the-touch jet of ionized gases, or cold atmospheric plasma (“CAP”). Read the GW Today article on this promising technology and the partnership.